• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - Viagra
Tag:

Viagra

Health

Viagra may treat deadly disease in children

by Chief Editor March 14, 2026
written by Chief Editor

Viagra’s Unexpected Second Life: Hope for Children with a Deadly Genetic Disease

The familiar little blue pill, known worldwide for treating erectile dysfunction, is showing remarkable promise in a completely different arena: combating Leigh syndrome, a devastating neurological disorder that primarily affects young children. Latest research suggests sildenafil, the active ingredient in Viagra, could offer a lifeline to families facing this heartbreaking condition, where most children tragically die before the age of three.

Understanding Leigh Syndrome: A Rare and Relentless Condition

Leigh syndrome is a rare mitochondrial disease, impacting approximately one in every 40,000 births. It stems from genetic mutations that cripple the mitochondria – the “power plants” of cells – hindering their ability to produce sufficient energy. This energy deficit disproportionately affects the brain and muscles, leading to a cascade of debilitating symptoms.

Early signs often include vomiting, diarrhea, and difficulty swallowing. As the disease progresses, children may experience loss of motor skills, developmental delays, seizures, breathing problems, and feeding difficulties. The lack of approved therapies to slow the disease’s progression makes finding effective treatments incredibly urgent.

How Sildenafil Offers a Spark of Hope

Researchers discovered that sildenafil could “switch on” genes linked to brain development and reduce harmful molecular changes associated with Leigh syndrome when tested on lab-grown cells. Further experiments using miniature, three-dimensional brain models mimicking human tissue showed the drug boosted nerve cell growth, improved energy metabolism, and extended lifespan in mice and pigs with Leigh syndrome mutations.

Early Clinical Trial Results: Promising Improvements

A small initial clinical trial involving six patients with Leigh syndrome, aged between 9 months and 38 years, yielded encouraging results. Patients who began taking sildenafil demonstrated improvements in muscular strength and mobility. In one remarkable case, a child’s walking distance increased tenfold, from 500 to 5,000 meters.

Beyond physical improvements, patients experienced fewer metabolic crises – life-threatening emergencies caused by the body’s inability to convert food into energy. One patient even stopped experiencing seizures, while others showed modest gains in cognitive ability. These effects, researchers say, significantly improve the quality of life for those living with Leigh syndrome.

Beyond Erectile Dysfunction: Sildenafil’s Expanding Role

While widely recognized for its use in treating erectile dysfunction, sildenafil is already approved for treating pulmonary arterial hypertension in children – a rare condition causing high blood pressure in the lungs. This existing safety data for pediatric use was a key factor in the decision to explore its potential for Leigh syndrome.

The Future of Sildenafil and Neurodegenerative Diseases

The potential of sildenafil extends beyond Leigh syndrome. Research, including studies highlighted by the McGill University Health Centre, suggests it may have neuroprotective and neurorestorative properties, potentially benefiting individuals with brain injuries. A recent study showed sildenafil could be a possible solution for repairing brain damage caused by neonatal encephalopathy, a condition where babies experience oxygen deprivation during birth.

Pro Tip:

The success of repurposing sildenafil highlights the potential of “drug repurposing” – identifying new uses for existing medications. This approach can significantly accelerate the development of treatments for rare and neglected diseases, as safety profiles are already established.

What’s Next? A Larger Clinical Trial on the Horizon

Researchers are planning a larger, placebo-controlled clinical trial involving 60 to 70 patients across several European countries. This next phase aims to confirm the initial findings and establish sildenafil as a viable treatment option for Leigh syndrome. However, researchers urge families not to self-medicate and to collaborate with medical professionals if considering sildenafil treatment.

Frequently Asked Questions (FAQ)

  • What is Leigh syndrome? A rare, devastating genetic disorder affecting the mitochondria, leading to energy deficiencies in the brain and muscles.
  • How does sildenafil facilitate? Research suggests it improves mitochondrial function, strengthens neurons, and boosts nerve cell growth.
  • Is sildenafil safe for children? It’s already approved for treating pulmonary arterial hypertension in children, providing a foundation of safety data.
  • When will sildenafil be available as a treatment for Leigh syndrome? Further clinical trials are needed before it can be widely adopted as a treatment.

Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.

Want to learn more about rare genetic disorders and ongoing research? Explore additional resources on the National Organization for Rare Disorders (NORD) website.

March 14, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Viagra ingredient improves symptoms in patients with Leigh syndrome

by Chief Editor March 11, 2026
written by Chief Editor

Viagra Ingredient Offers Hope for Rare Genetic Disorder, Leigh Syndrome

A surprising discovery is offering a beacon of hope for families affected by Leigh syndrome, a devastating and previously untreatable genetic disorder. Sildenafil, the active ingredient in Viagra, has shown promising results in improving symptoms and potentially slowing the progression of this rare childhood disease.

Understanding Leigh Syndrome: A Race Against Time

Leigh syndrome is a congenital disorder affecting the brain and muscles, stemming from defective energy metabolism. Typically manifesting in infancy or early childhood, it leads to severe neurological and muscular symptoms, including epileptic seizures, muscle weakness, and developmental delays. Currently, there is no approved drug therapy, and life expectancy is significantly reduced, with many children dying within a few years of diagnosis. Affecting approximately one in 36,000 live births, Leigh syndrome presents significant challenges for research due to its rarity.

From Erectile Dysfunction Drug to Potential Breakthrough

Researchers at Charité – Universitätsmedizin Berlin, Heinrich Heine University Düsseldorf, and the Fraunhofer Institute for Translational Medicine and Pharmacology, alongside international collaborators, stumbled upon this unexpected therapeutic avenue. Sildenafil, traditionally used to treat erectile dysfunction, also has vasodilatory properties and is used to treat pulmonary hypertension in infants. A pilot study involving six patients aged between 9 months and 38 years revealed encouraging outcomes.

Positive Results in Pilot Study: A Glimmer of Improvement

Within months of initiating sildenafil treatment, patients exhibited improvements in muscular strength and, in some cases, a reduction in neurological symptoms. Notably, patients experienced faster recovery from metabolic crises – sudden worsening of the energy metabolism – and some even saw a complete suppression of previously frequent epileptic seizures. One child’s walking distance increased tenfold, from 500 to 5,000 meters, demonstrating a significant improvement in physical function.

Innovative Research Methods: Stem Cells and Drug Screening

The identification of sildenafil as a potential treatment involved a novel approach. Researchers utilized induced pluripotent stem cells (iPS cells) derived from patient skin cells to create nerve cells that mirrored the defective metabolism characteristic of Leigh syndrome. They then screened over 5,500 existing drugs for their effect on these cells, identifying sildenafil as a promising candidate. Further testing in three-dimensional brain organoids and animal models corroborated these findings.

Orphan Drug Designation and Future Clinical Trials

The European Medicines Agency (EMA) has granted sildenafil orphan drug designation, which facilitates a streamlined approval process for therapies targeting rare diseases. A Europe-wide, placebo-controlled clinical trial is now planned as part of the SIMPATHIC EU project to validate these initial results and pave the way for potential approval of sildenafil as a treatment for Leigh syndrome.

Why This Matters: The Challenges of Rare Disease Research

The success story highlights the difficulties inherent in researching rare diseases. Small patient populations craft large-scale studies challenging, necessitating international collaboration and innovative methodologies. The use of iPS cells and high-throughput drug screening represents a significant advancement in overcoming these hurdles.

Frequently Asked Questions

What is Leigh syndrome? Leigh syndrome is a rare, inherited metabolic disorder that affects the brain and muscles, leading to severe neurological symptoms.

How does sildenafil help with Leigh syndrome? Sildenafil appears to improve nerve cell function and energy metabolism, leading to improvements in muscle strength and a reduction in symptoms.

Is sildenafil a cure for Leigh syndrome? Currently, sildenafil is not a cure, but it shows promise as a disease-modifying treatment to improve quality of life and potentially slow disease progression.

What are the next steps in research? A large-scale, placebo-controlled clinical trial is planned to confirm the initial findings and seek regulatory approval for sildenafil as a treatment for Leigh syndrome.

Where can I find more information about Leigh syndrome? Further information can be found through medical professionals and organizations dedicated to mitochondrial diseases.

Did you know? The drug screening process involved testing over 5,500 existing compounds, making it the largest of its kind for Leigh syndrome to date.

If you or someone you know is affected by Leigh syndrome, please consult with a medical professional to discuss potential treatment options and participate in ongoing research efforts.

March 11, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Battle to get ‘female Viagra’ to market — and how ‘Grey’s Anatomy’ played a role

by Chief Editor March 6, 2026
written by Chief Editor

The Ongoing Quest for Female Sexual Wellness: Beyond the “Pink Pill”

For decades, pharmaceutical solutions for male sexual dysfunction, like Viagra and Cialis, have been readily available. Yet, a comparable option for women has been a more elusive goal. Now, a new documentary, “The Pink Pill: Sex, Drugs & Who Has Control,” premiering on Paramount+, shines a spotlight on Addyi, the first FDA-approved pill aimed at treating hypoactive sexual desire disorder (HSDD) in women, and the challenging path it took to market.

Addyi has undergone a few makeovers before hitting pharmacy shelves. It was once an antidepressant before evolving into medicine to address low sex drive. Courtesy of Paramount

From Antidepressant to Addressing HSDD

Initially developed by Boehringer Ingelheim as an antidepressant, the pill, clinically known as flibanserin, didn’t prove effective for depression. Researchers then explored its potential to address HSDD, a condition characterized by low or no sex drive for at least six months. Addyi works differently than medications like Viagra, which increase blood flow. Instead, it focuses on balancing neurotransmitters – dopamine, serotonin, and norepinephrine – in the brain to potentially boost sexual desire.

A Rocky Road to FDA Approval

The journey to FDA approval was far from smooth. The drug faced two rejections in 2010 and 2013 due to concerns about modest benefits and potential side effects, including low blood pressure, dizziness, and fainting, especially when combined with alcohol. The FDA also required special training for prescribers and pharmacists to educate patients about these risks.

The “Even the Score” Campaign and Gender Equity

Following the second rejection, Sprout Pharmaceuticals acquired the rights to flibanserin. Sprout, led by co-founder Cindy Eckert, launched the “Even the Score” public relations campaign. This initiative argued that the lack of approved treatments for female sexual dysfunction, compared to the abundance for men, represented a gender bias in drug approvals. The campaign included parody ads referencing Viagra, aiming to highlight this perceived inequity. This campaign is credited with influencing the FDA’s eventual 2015 approval of Addyi, though it came with a “black box” warning – the most stringent safety warning – regarding the risks associated with alcohol consumption.

Sales Challenges and Expanded Approval

Despite the approval, Addyi’s initial sales fell short of expectations, partly due to a significant price increase and marketing missteps. Valeant Pharmaceuticals acquired Sprout for approximately $1 billion, but the drug was eventually returned to its original shareholders. However, in December 2025, the FDA expanded approval to include postmenopausal women under 65. This expansion occurred despite a warning letter from the FDA to Eckert regarding a social media post that potentially misrepresented the drug’s safety and effectiveness.

Future Trends in Female Sexual Wellness

Addyi’s story highlights a growing awareness of female sexual health needs and the challenges in developing and marketing treatments. Several trends suggest a shift in this landscape:

Beyond Pharmacology: Holistic Approaches

While pharmaceutical options like Addyi and bremelanotide (Vyleesi, an injectable medication also approved for HSDD) are available, there’s increasing interest in holistic approaches. These include sex therapy, mindfulness techniques, pelvic floor exercises, and addressing underlying psychological factors contributing to low libido. The focus is shifting towards a more comprehensive understanding of sexual well-being.

Personalized Medicine and Biomarkers

Future treatments may be tailored to individual needs based on biomarkers and genetic factors. Research is underway to identify biological markers associated with HSDD, potentially leading to more targeted and effective therapies. This personalized approach could minimize side effects and maximize benefits.

Technological Innovations

Technology is playing an increasing role in sexual wellness. Wearable sensors and apps are being developed to track sexual activity, identify patterns, and provide personalized recommendations. Telemedicine platforms are also expanding access to sexual health services, particularly for women in remote areas or those who prefer discreet consultations.

Increased Open Dialogue and Reduced Stigma

The conversation around female sexual health is becoming more open, thanks in part to documentaries like “The Pink Pill” and increased media coverage. This reduced stigma encourages women to seek assist and explore available options without shame or embarrassment.

FAQ

What is HSDD? Hypoactive sexual desire disorder is characterized by persistently low or absent sexual desire for at least six months.

How does Addyi work? Addyi is thought to work by balancing neurotransmitters in the brain that regulate sexual desire.

Is Addyi right for everyone? Addyi is only approved for premenopausal and postmenopausal women (<65) with HSDD and is not without potential side effects.

Are there alternatives to Addyi? Yes, alternatives include bremelanotide (Vyleesi), sex therapy, and lifestyle changes.

Pro Tip: If you’re experiencing persistent low libido, consult with a healthcare professional to discuss potential causes and treatment options.

Want to learn more about women’s health? Explore our articles on hormone therapy and menopause management.

Did you know? Approximately 10% of women are affected by HSDD, yet many do not seek treatment due to stigma or lack of awareness.

Share your thoughts! Have you or someone you know experienced challenges with low libido? Leave a comment below.

March 6, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Does Viagra Reduce Alzheimer’s Risk? Exploring the Link Between the Medication and Cognitive Health

by Chief Editor April 7, 2025
written by Chief Editor

The Unlikely Hero: Viagra’s Potential in Alzheimer’s Prevention

The well-known medication Viagra, recognized primarily for its role in treating erectile dysfunction, might be poised for a new chapter in medical science. Recent research suggests it could play a role in reducing the risk of Alzheimer’s disease. A study conducted by the Cleveland Clinic found that individuals who took sildenafil, branded as Viagra, showed a significant decrease—between 30% and 54%—in Alzheimer’s risk.

Understanding Alzheimer’s and Viagra’s Mechanism

Alzheimer’s disease is a complex, neurodegenerative condition affecting over 55 million people globally. It’s characterized by the accumulation of harmful proteins in the brain, disrupting neuron communication essential for cognitive functions. Interestingly, Viagra appears to lower the levels of the tau protein, a key player in this process.

Dr. Feixiong Cheng, a geneticist and chief neurologist, explains that Viagra works by enhancing cerebral blood flow and reducing inflammation, both crucial for slowing down Alzheimer’s neurodegenerative effects. “Viagra triggers a neurological protective effect through its interaction with Alzheimer’s biology,” he notes.

Viagra’s Edge: Repoziționing in Modern Medicine

Medicine is seeing a growing trend of “repoziționing,” where existing drugs are re-evaluated for new therapeutic uses. Viagra, with its long history of safe use and FDA approval for over two decades, is an ideal candidate for this.

Although several newly-developed Alzheimer’s drugs targeting brain proteins have fallen short, the focus is turning back to established medications. “The potential for Viagra in neuroprotection excites us immensely,” says Dr. Cheng.

Pretty Potent Against Alzheimer’s?

The implications of these findings are profound if validated through further randomized clinical trials, which Dr. Cheng estimates could be two to three years away. The studies aim to determine an effective dose and regimen for potential Alzheimer’s prevention.

“Research is a meticulous process, yet we harbor hope that a drug, whether it’s Viagra or another, might soon mitigate Alzheimer’s risk,” adds Dr. Cheng.

Who Benefits? Viagra’s Broader Reach

Research suggests beneficial effects not just for men but also women who have been prescribed Viagra for pulmonary hypertension. While the sample for women was limited, the protective effects against Alzheimer’s were evident.

The broader application might make Viagra a cornerstone in Alzheimer’s preventive strategies, provided it withstands future scientific scrutiny. It highlights Viagra’s evolution from a mere sexual health aid to a potential neuroprotective agent.

A Call to Action: Exploring New Frontiers

The search for reliable Alzheimer’s prevention continues, and keeping abreast of these developments is crucial. Stay tuned to explore more on innovative medical breakthroughs and share your thoughts on such fascinating research.

Frequently Asked Questions

How immediate are the effects of Viagra on Alzheimer’s prevention?

Currently, Viagra cannot be prescribed for Alzheimer’s prevention until further validated by clinical trials.

Is Viagra effective for both men and women?

Yes, research indicates potential benefits for both genders, although more focused studies are necessary for women.

What should patients consider before using Viagra for Alzheimer’s?

Consult with healthcare providers to discuss suitability based on individual health profiles, especially regarding blood pressure or concurrent medications.

Could Viagra eventually become a standard preventive treatment for Alzheimer’s?

While promising, its use for Alzheimer’s hinges on comprehensive clinical research outcomes over the next few years.

Related Reading: Explore more insights into current medical breakthroughs here.

April 7, 2025 0 comments
0 FacebookTwitterPinterestEmail
Health

Erektionsprobleme: Wie der Beckenboden für anhaltende Erektionen sorgen kann

by Chief Editor March 20, 2025
written by Chief Editor

The Crucial Role of Pelvic Floor Muscles in Sexual Health and Overall Well-being

The pelvic floor muscles are not only indispensable for supporting the bladder and intestines during physical activities like running, sneezing, laughing, and jumping, but they also play a pivotal role in male sexual health.

Understanding Penile Rigidity and Muscle Function

Professor Sommer emphasizes the importance of the penile rigidity muscle in maintaining an erection. “This muscle is key in holding blood within the erectile tissues, thus preserving the necessary firmness for sexual intercourse,” he says. In practice, patients with weak pelvic floor muscles are advised on specific exercises to enhance their strength.

The Complex Interplay of Factors Leading to Erectile Dysfunction

Erectile dysfunction (ED) is a multifaceted issue, influenced by various factors including lifestyle choices. Obesity, for instance, has been shown to negatively impact erectile function. This connection highlights the importance of maintaining a healthy weight. MDR’s article on the link between heart health and erectile function illustrates this point further.

The Penis as an Indicator of Cardiovascular Health

The saying that “the penis is the antenna of the heart” carries scientific weight. Conditions impairing blood flow, such as atherosclerosis, manifest first in the penis. This makes the penis not only a crucial indicator of sexual health but also early warning for potential heart conditions.

Future Trends in Managing Pelvic Floor Health and Erectile Dysfunction

Innovations in Diagnostic Tools

Emerging technologies like advanced electroencephalography (EEG) are reshaping how pelvic floor strength is measured, providing more personalized treatment options.

Did you know? Non-invasive tests are becoming popular for early detection of sexual dysfunction and related cardiovascular risks.

Integrating Lifestyle Interventions

Future trends point towards holistic approaches that incorporate diet, exercise, and mental health strategies to improve sexual well-being. Healthline’s insights on improving penile health include recommended foods and activities.

Pro Tip: Incorporate pelvic floor exercises into your daily routine for long-term benefits.

The Rise of Personalized Medicine

With the advent of genetic testing and personal health tracking devices, treatment for ED is becoming more tailored to individual needs. Innovative treatments, such as hormone therapy and localized injections, are being refined based on a patient’s specific health profile.

FAQ Section

How can I strengthen my pelvic floor muscles?

Simple exercises like Kegels can be performed discreetly. Consistency is key to seeing improvement.

Are there natural remedies for ED?

Nutritional supplements like L-arginine have shown promise, but consult with a healthcare professional first.

Can pelvic floor issues affect women?

Yes, women can also experience pelvic floor weakness, impacting urinary control and sexual satisfaction.

Conclusion

Understanding and addressing pelvic floor health is crucial not only for sexual performance but also as a preventative measure for heart health. Explore more on our website about maintaining overall well-being.

Engage with our community by commenting below or subscribe to our newsletter for the latest health insights and news.

March 20, 2025 0 comments
0 FacebookTwitterPinterestEmail

Recent Posts

  • Nothing Ear (open) Now Available in New Blue Color

    May 11, 2026
  • Heti Hetesben: Megafon, Majka

    May 11, 2026
  • Artis Brno Defeats Opava 2:0, Keeps Post-Season Hopes Alive

    May 11, 2026
  • Cork locals object to council’s go-ahead for bus drop-off area at Páirc Uí Chaoimh

    May 11, 2026
  • Metcalf’s Future Uncertain; Boyd Re-Signed by Warriors

    May 11, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: o f f i c e @byohosting.com


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World